DYADIC INTERNATIONAL INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
DYADIC INTERNATIONAL INC (DYAI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 516.25 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 516.25K shares, a 23.35% decline year-over-year.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 698.50K shares, a 15.92% decline from fiscal 2024.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 830.73K shares, a 3.15% increase from fiscal 2023.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 805.35K shares, a 6.98% decline from fiscal 2022.
- DYADIC INTERNATIONAL INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 865.83K shares, a 0.57% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 516.25K shares 10-Q · filed 2026-08-12 | 516.25K shares derived: sum of 3 quarters · filed 2026-08-12 | 516.25K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 516.25K shares 10-Q · filed 2026-05-13 | 516.25K shares derived: sum of 2 quarters · filed 2026-05-13 | 516.25K shares derived: sum of 3 quarters · filed 2026-05-13 | 541.25K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-25 | 25.00K shares derived: sum of 3 quarters · filed 2026-03-25 | 698.50K shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 25.00K shares derived: sum of 2 quarters · filed 2025-11-12 | 698.50K shares 10-Q · filed 2025-11-12 | 691.63K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | 25.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 698.50K shares 10-Q · filed 2025-08-13 | 691.63K shares derived: sum of 3 quarters · filed 2026-03-25 | 716.63K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | 673.50K shares 10-Q · filed 2025-05-14 | 666.63K shares derived: sum of 2 quarters · filed 2026-03-25 | 691.63K shares derived: sum of 3 quarters · filed 2026-03-25 | 731.63K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | -6.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 18.13K shares derived: sum of 2 quarters · filed 2026-03-25 | 58.13K shares derived: sum of 3 quarters · filed 2026-03-25 | 830.73K shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 65.00K shares derived: sum of 2 quarters · filed 2024-11-12 | 837.60K shares 10-Q · filed 2024-11-12 | 842.60K shares derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-06-30 | 40.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 812.60K shares 10-Q · filed 2024-08-13 | 817.60K shares derived: sum of 3 quarters · filed 2025-03-26 | 872.60K shares derived: sum of 4 quarters · filed 2025-03-26 |
| 2024-03-31 | 772.60K shares 10-Q · filed 2024-05-14 | 777.60K shares derived: sum of 2 quarters · filed 2025-03-26 | 832.60K shares derived: sum of 3 quarters · filed 2025-03-26 | 870.10K shares derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-12-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 60.00K shares derived: sum of 2 quarters · filed 2025-03-26 | 97.50K shares derived: sum of 3 quarters · filed 2025-03-26 | 805.35K shares 10-K · filed 2025-03-26 |
| 2023-09-30 | 55.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 92.50K shares derived: sum of 2 quarters · filed 2023-11-08 | 800.35K shares 10-Q · filed 2023-11-08 | 800.35K shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | 37.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 745.35K shares 10-Q · filed 2023-08-09 | 745.35K shares derived: sum of 3 quarters · filed 2024-03-28 | 745.35K shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | 707.85K shares 10-Q · filed 2023-05-10 | 707.85K shares derived: sum of 2 quarters · filed 2024-03-28 | 707.85K shares derived: sum of 3 quarters · filed 2024-03-28 | 857.85K shares derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 150.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 865.83K shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 150.00K shares derived: sum of 2 quarters · filed 2022-11-10 | 865.83K shares 10-Q · filed 2022-11-10 | 965.83K shares derived: sum of 4 quarters · filed 2023-03-29 |
| 2022-06-30 | 150.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 865.83K shares 10-Q · filed 2022-08-10 | 965.83K shares derived: sum of 3 quarters · filed 2023-03-29 | 990.83K shares derived: sum of 4 quarters · filed 2023-03-29 |
| 2022-03-31 | 715.83K shares 10-Q · filed 2022-05-12 | 815.83K shares derived: sum of 2 quarters · filed 2023-03-29 | 840.83K shares derived: sum of 3 quarters · filed 2023-03-29 | 840.83K shares derived: sum of 4 quarters · filed 2023-03-29 |
| 2021-12-31 | 100.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 125.00K shares derived: sum of 2 quarters · filed 2023-03-29 | 125.00K shares derived: sum of 3 quarters · filed 2023-03-29 | 870.83K shares 10-K · filed 2023-03-29 |
| 2021-09-30 | 25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 25.00K shares derived: sum of 2 quarters · filed 2021-11-10 | 770.83K shares 10-Q · filed 2021-11-10 | 770.83K shares derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 745.83K shares 10-Q · filed 2021-08-12 | 745.83K shares derived: sum of 3 quarters · filed 2022-03-29 | 745.83K shares derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-03-31 | 745.83K shares 10-Q · filed 2021-05-13 | 745.83K shares derived: sum of 2 quarters · filed 2022-03-29 | 745.83K shares derived: sum of 3 quarters · filed 2022-03-29 | 745.83K shares derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-29 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-29 | 913.00K shares 10-K · filed 2022-03-29 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-12 | 913.00K shares 10-Q · filed 2020-11-12 | 913.00K shares derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 913.00K shares 10-Q · filed 2020-08-13 | 913.00K shares derived: sum of 3 quarters · filed 2021-03-30 | 913.00K shares derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-03-31 | 913.00K shares 10-Q · filed 2020-05-14 | 913.00K shares derived: sum of 2 quarters · filed 2021-03-30 | 913.00K shares derived: sum of 3 quarters · filed 2021-03-30 | 1.01M shares derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-30 | 100.00K shares derived: sum of 3 quarters · filed 2021-03-30 | 1.09M shares 10-K · filed 2021-03-30 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 100.00K shares derived: sum of 2 quarters · filed 2019-11-13 | 1.09M shares 10-Q · filed 2019-11-13 | |
| 2019-06-30 | 100.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | 1.09M shares 10-Q · filed 2019-08-13 | ||
| 2019-03-31 | 989.00K shares 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 1.12M shares 10-K · filed 2020-03-30 | |||
| 2016-12-31 | 660.56K shares 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |